{"id":404460,"date":"2020-12-22T08:33:38","date_gmt":"2020-12-22T13:33:38","guid":{"rendered":"http:\/\/www.marketnewsdesk.com\/?p=404460"},"modified":"2020-12-22T08:33:38","modified_gmt":"2020-12-22T13:33:38","slug":"barer-institute-announces-licensing-agreement-with-princeton-universitys-office-of-technology-licensing-for-shmt-inhibitor-program","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/barer-institute-announces-licensing-agreement-with-princeton-universitys-office-of-technology-licensing-for-shmt-inhibitor-program\/","title":{"rendered":"Barer Institute Announces Licensing Agreement with Princeton University&#8217;s Office of Technology Licensing for SHMT Inhibitor Program"},"content":{"rendered":"<div class=\"xn-newslines\">\n<p class=\"xn-distributor\">PR Newswire<\/p>\n<\/p><\/div>\n<div class=\"xn-content\">\n<p>\n        <span class=\"xn-location\">NEWARK, N.J.<\/span>, <span class=\"xn-chron\">Dec. 22, 2020<\/span> \/PRNewswire\/ &#8212;\u00a0The Barer Institute, a cancer drug development initiative of <a target=\"_blank\" href=\"https:\/\/c212.net\/c\/link\/?t=0&amp;l=en&amp;o=3020357-1&amp;h=655715257&amp;u=https%3A%2F%2Frafaelholdings.com%2F&amp;a=Rafael+Holdings%2C+Inc.\" rel=\"nofollow noopener noreferrer\">Rafael Holdings, Inc.<\/a>, (NYSE: RFL), today announced that it has reached an agreement with <span class=\"xn-org\">Princeton University&#8217;s<\/span> Office of Technology Licensing for technology from the laboratory of Professor <span class=\"xn-person\">Joshua Rabinowitz<\/span>, in the Department of Chemistry, <span class=\"xn-org\">Princeton University<\/span>, for an exclusive worldwide license to its SHMT (serine hydroxymethyltransferase) inhibitor program and related intellectual property. <\/p>\n<div class=\"PRN_ImbeddedAssetReference\" id=\"DivAssetPlaceHolder1\">\n<p>\n          <a href=\"https:\/\/mma.prnewswire.com\/media\/702995\/Rafael_Holdings_Logo.html\" target=\"_blank\" rel=\"nofollow noopener noreferrer\"><br \/>\n            <img decoding=\"async\" src=\"https:\/\/mma.prnewswire.com\/media\/702995\/Rafael_Holdings_Logo.jpg\" title=\"Rafael Holdings holds commercial real estate assets and interests in two clinical stage pharmaceutical companies.  The pharmaceutical holdings consist of interests in Rafael Pharmaceuticals, Inc. and a majority stake in Lipomedix Pharmaceuticals Ltd., both of which are focused on development and commercialization of drugs in the oncology space.  For more information, visit www.rafaelholdings.com (PRNewsfoto\/Rafael Holdings, Inc.)\" alt=\"Rafael Holdings holds commercial real estate assets and interests in two clinical stage pharmaceutical companies.  The pharmaceutical holdings consist of interests in Rafael Pharmaceuticals, Inc. and a majority stake in Lipomedix Pharmaceuticals Ltd., both of which are focused on development and commercialization of drugs in the oncology space.  For more information, visit www.rafaelholdings.com (PRNewsfoto\/Rafael Holdings, Inc.)\" \/><br \/>\n          <\/a>\n        <\/p>\n<\/p><\/div>\n<p>SHMT is critical source of 1\u2013carbon units utilized in cellular nucleotide synthesis.\u00a0SHMT isoforms are upregulated in numerous cancers and have been shown to be a valuable target for metabolic cancer treatment. <\/p>\n<p>Professor Rabinowitz commented, &#8220;I am looking forward to working with the Barer Institute, and their scientists and advisors, to turn our discoveries into life-saving drugs. The leading current antifolate, pemetrexed, was discovered by <span class=\"xn-person\">Ted Taylor&#8217;s<\/span> lab in <span class=\"xn-location\">Princeton&#8217;s<\/span> Chemistry Department, and I believe that our SHMT inhibitors will prove to be the next major class of folate-targeting therapeutics.&#8221;<\/p>\n<p>Dr. <span class=\"xn-person\">Ari Landon<\/span>, Director of the Barer Institute, said, &#8220;We are excited to work with Professor Rabinowitz and build on his pioneering work on SHMT inhibitors.\u00a0The Rabinowitz Lab is a leading metabolomics-focused research lab in the country, and its cutting-edge analytical work has already significantly extended our understanding of metabolic operations.\u00a0This agreement enables us to explore SHMT inhibitors for potential commercial development.&#8221;\u00a0 <\/p>\n<p>\n        <b>About Rafael Holdings, Inc.:<br \/><\/b>Rafael Holdings is focused on development of novel cancer therapies.\u00a0The company is a significant investor in two clinical stage oncology companies, Rafael Pharmaceuticals, Inc. and LipoMedix Pharmaceuticals Ltd.\u00a0Through its wholly owned Barer Institute subsidiary, the company is developing compounds focused on the regulation of cancer metabolism.\u00a0The company also holds commercial real estate assets in <span class=\"xn-location\">New Jersey<\/span> and <span class=\"xn-location\">Jerusalem<\/span>. For more information, visit <a target=\"_blank\" href=\"https:\/\/c212.net\/c\/link\/?t=0&amp;l=en&amp;o=3020357-1&amp;h=1307385967&amp;u=https%3A%2F%2Frafaelholdings.com%2F&amp;a=rafaelholdings.com\" rel=\"nofollow noopener noreferrer\">rafaelholdings.com<\/a>.<\/p>\n<p>\u00a0<\/p>\n<div class=\"PRN_ImbeddedAssetReference\" id=\"DivAssetPlaceHolder2\"><\/div>\n<p id=\"PURL\">\n        <img loading=\"lazy\" decoding=\"async\" title=\"Cision\" width=\"12\" height=\"12\" alt=\"Cision\" src=\"https:\/\/c212.net\/c\/img\/favicon.png?sn=NY31522&amp;sd=2020-12-22\" \/> View original content to download multimedia:<a id=\"PRNURL\" rel=\"nofollow\" href=\"http:\/\/www.prnewswire.com\/news-releases\/barer-institute-announces-licensing-agreement-with-princeton-universitys-office-of-technology-licensing-for-shmt-inhibitor-program-301197309.html\">http:\/\/www.prnewswire.com\/news-releases\/barer-institute-announces-licensing-agreement-with-princeton-universitys-office-of-technology-licensing-for-shmt-inhibitor-program-301197309.html<\/a><\/p>\n<p>SOURCE  Rafael Holdings, Inc.<\/p>\n<\/p><\/div>\n<p>    <img decoding=\"async\" alt=\"\" src=\"https:\/\/rt.prnewswire.com\/rt.gif?NewsItemId=NY31522&amp;Transmission_Id=202012220830PR_NEWS_USPR_____NY31522&amp;DateId=20201222\" style=\"border:0px;width:1px;height:1px\" \/><\/p>\n","protected":false},"excerpt":{"rendered":"<p>PR Newswire NEWARK, N.J., Dec. 22, 2020 \/PRNewswire\/ &#8212;\u00a0The Barer Institute, a cancer drug development initiative of Rafael Holdings, Inc., (NYSE: RFL), today announced that it has reached an agreement with Princeton University&#8217;s Office of Technology Licensing for technology from the laboratory of Professor Joshua Rabinowitz, in the Department of Chemistry, Princeton University, for an exclusive worldwide license to its SHMT (serine hydroxymethyltransferase) inhibitor program and related intellectual property. SHMT is critical source of 1\u2013carbon units utilized in cellular nucleotide synthesis.\u00a0SHMT isoforms are upregulated in numerous cancers and have been shown to be a valuable target for metabolic cancer treatment. Professor Rabinowitz commented, &#8220;I am looking forward to working with the Barer Institute, and their scientists and advisors, to turn &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/barer-institute-announces-licensing-agreement-with-princeton-universitys-office-of-technology-licensing-for-shmt-inhibitor-program\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Barer Institute Announces Licensing Agreement with Princeton University&#8217;s Office of Technology Licensing for SHMT Inhibitor Program&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-404460","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Barer Institute Announces Licensing Agreement with Princeton University&#039;s Office of Technology Licensing for SHMT Inhibitor Program - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/barer-institute-announces-licensing-agreement-with-princeton-universitys-office-of-technology-licensing-for-shmt-inhibitor-program\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Barer Institute Announces Licensing Agreement with Princeton University&#039;s Office of Technology Licensing for SHMT Inhibitor Program - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"PR Newswire NEWARK, N.J., Dec. 22, 2020 \/PRNewswire\/ &#8212;\u00a0The Barer Institute, a cancer drug development initiative of Rafael Holdings, Inc., (NYSE: RFL), today announced that it has reached an agreement with Princeton University&#8217;s Office of Technology Licensing for technology from the laboratory of Professor Joshua Rabinowitz, in the Department of Chemistry, Princeton University, for an exclusive worldwide license to its SHMT (serine hydroxymethyltransferase) inhibitor program and related intellectual property. SHMT is critical source of 1\u2013carbon units utilized in cellular nucleotide synthesis.\u00a0SHMT isoforms are upregulated in numerous cancers and have been shown to be a valuable target for metabolic cancer treatment. Professor Rabinowitz commented, &#8220;I am looking forward to working with the Barer Institute, and their scientists and advisors, to turn &hellip; Continue reading &quot;Barer Institute Announces Licensing Agreement with Princeton University&#8217;s Office of Technology Licensing for SHMT Inhibitor Program&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/barer-institute-announces-licensing-agreement-with-princeton-universitys-office-of-technology-licensing-for-shmt-inhibitor-program\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2020-12-22T13:33:38+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mma.prnewswire.com\/media\/702995\/Rafael_Holdings_Logo.jpg\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/barer-institute-announces-licensing-agreement-with-princeton-universitys-office-of-technology-licensing-for-shmt-inhibitor-program\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/barer-institute-announces-licensing-agreement-with-princeton-universitys-office-of-technology-licensing-for-shmt-inhibitor-program\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Barer Institute Announces Licensing Agreement with Princeton University&#8217;s Office of Technology Licensing for SHMT Inhibitor Program\",\"datePublished\":\"2020-12-22T13:33:38+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/barer-institute-announces-licensing-agreement-with-princeton-universitys-office-of-technology-licensing-for-shmt-inhibitor-program\\\/\"},\"wordCount\":327,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/barer-institute-announces-licensing-agreement-with-princeton-universitys-office-of-technology-licensing-for-shmt-inhibitor-program\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/702995\\\/Rafael_Holdings_Logo.jpg\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/barer-institute-announces-licensing-agreement-with-princeton-universitys-office-of-technology-licensing-for-shmt-inhibitor-program\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/barer-institute-announces-licensing-agreement-with-princeton-universitys-office-of-technology-licensing-for-shmt-inhibitor-program\\\/\",\"name\":\"Barer Institute Announces Licensing Agreement with Princeton University's Office of Technology Licensing for SHMT Inhibitor Program - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/barer-institute-announces-licensing-agreement-with-princeton-universitys-office-of-technology-licensing-for-shmt-inhibitor-program\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/barer-institute-announces-licensing-agreement-with-princeton-universitys-office-of-technology-licensing-for-shmt-inhibitor-program\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/702995\\\/Rafael_Holdings_Logo.jpg\",\"datePublished\":\"2020-12-22T13:33:38+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/barer-institute-announces-licensing-agreement-with-princeton-universitys-office-of-technology-licensing-for-shmt-inhibitor-program\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/barer-institute-announces-licensing-agreement-with-princeton-universitys-office-of-technology-licensing-for-shmt-inhibitor-program\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/barer-institute-announces-licensing-agreement-with-princeton-universitys-office-of-technology-licensing-for-shmt-inhibitor-program\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/702995\\\/Rafael_Holdings_Logo.jpg\",\"contentUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/702995\\\/Rafael_Holdings_Logo.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/barer-institute-announces-licensing-agreement-with-princeton-universitys-office-of-technology-licensing-for-shmt-inhibitor-program\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Barer Institute Announces Licensing Agreement with Princeton University&#8217;s Office of Technology Licensing for SHMT Inhibitor Program\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Barer Institute Announces Licensing Agreement with Princeton University's Office of Technology Licensing for SHMT Inhibitor Program - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/barer-institute-announces-licensing-agreement-with-princeton-universitys-office-of-technology-licensing-for-shmt-inhibitor-program\/","og_locale":"en_US","og_type":"article","og_title":"Barer Institute Announces Licensing Agreement with Princeton University's Office of Technology Licensing for SHMT Inhibitor Program - Market Newsdesk","og_description":"PR Newswire NEWARK, N.J., Dec. 22, 2020 \/PRNewswire\/ &#8212;\u00a0The Barer Institute, a cancer drug development initiative of Rafael Holdings, Inc., (NYSE: RFL), today announced that it has reached an agreement with Princeton University&#8217;s Office of Technology Licensing for technology from the laboratory of Professor Joshua Rabinowitz, in the Department of Chemistry, Princeton University, for an exclusive worldwide license to its SHMT (serine hydroxymethyltransferase) inhibitor program and related intellectual property. SHMT is critical source of 1\u2013carbon units utilized in cellular nucleotide synthesis.\u00a0SHMT isoforms are upregulated in numerous cancers and have been shown to be a valuable target for metabolic cancer treatment. Professor Rabinowitz commented, &#8220;I am looking forward to working with the Barer Institute, and their scientists and advisors, to turn &hellip; Continue reading \"Barer Institute Announces Licensing Agreement with Princeton University&#8217;s Office of Technology Licensing for SHMT Inhibitor Program\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/barer-institute-announces-licensing-agreement-with-princeton-universitys-office-of-technology-licensing-for-shmt-inhibitor-program\/","og_site_name":"Market Newsdesk","article_published_time":"2020-12-22T13:33:38+00:00","og_image":[{"url":"https:\/\/mma.prnewswire.com\/media\/702995\/Rafael_Holdings_Logo.jpg","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/barer-institute-announces-licensing-agreement-with-princeton-universitys-office-of-technology-licensing-for-shmt-inhibitor-program\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/barer-institute-announces-licensing-agreement-with-princeton-universitys-office-of-technology-licensing-for-shmt-inhibitor-program\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Barer Institute Announces Licensing Agreement with Princeton University&#8217;s Office of Technology Licensing for SHMT Inhibitor Program","datePublished":"2020-12-22T13:33:38+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/barer-institute-announces-licensing-agreement-with-princeton-universitys-office-of-technology-licensing-for-shmt-inhibitor-program\/"},"wordCount":327,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/barer-institute-announces-licensing-agreement-with-princeton-universitys-office-of-technology-licensing-for-shmt-inhibitor-program\/#primaryimage"},"thumbnailUrl":"https:\/\/mma.prnewswire.com\/media\/702995\/Rafael_Holdings_Logo.jpg","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/barer-institute-announces-licensing-agreement-with-princeton-universitys-office-of-technology-licensing-for-shmt-inhibitor-program\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/barer-institute-announces-licensing-agreement-with-princeton-universitys-office-of-technology-licensing-for-shmt-inhibitor-program\/","name":"Barer Institute Announces Licensing Agreement with Princeton University's Office of Technology Licensing for SHMT Inhibitor Program - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/barer-institute-announces-licensing-agreement-with-princeton-universitys-office-of-technology-licensing-for-shmt-inhibitor-program\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/barer-institute-announces-licensing-agreement-with-princeton-universitys-office-of-technology-licensing-for-shmt-inhibitor-program\/#primaryimage"},"thumbnailUrl":"https:\/\/mma.prnewswire.com\/media\/702995\/Rafael_Holdings_Logo.jpg","datePublished":"2020-12-22T13:33:38+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/barer-institute-announces-licensing-agreement-with-princeton-universitys-office-of-technology-licensing-for-shmt-inhibitor-program\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/barer-institute-announces-licensing-agreement-with-princeton-universitys-office-of-technology-licensing-for-shmt-inhibitor-program\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/barer-institute-announces-licensing-agreement-with-princeton-universitys-office-of-technology-licensing-for-shmt-inhibitor-program\/#primaryimage","url":"https:\/\/mma.prnewswire.com\/media\/702995\/Rafael_Holdings_Logo.jpg","contentUrl":"https:\/\/mma.prnewswire.com\/media\/702995\/Rafael_Holdings_Logo.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/barer-institute-announces-licensing-agreement-with-princeton-universitys-office-of-technology-licensing-for-shmt-inhibitor-program\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Barer Institute Announces Licensing Agreement with Princeton University&#8217;s Office of Technology Licensing for SHMT Inhibitor Program"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/404460","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=404460"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/404460\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=404460"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=404460"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=404460"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}